
Collegium Pharmaceutical, Inc
COLLNasdaqCIK 1267565HealthcareFiscal year ends Dec 31
Reports and events: 194 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-02-2516:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-001798 |
| 2021-01-0616:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-001485 |
| 2020-12-3016:53 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-20-140581 |
| 2020-11-0516:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-20-012856 |
| 2020-11-0516:03 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001558370-20-012836 |
| 2020-09-3008:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-110179 |
| 2020-09-2516:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-108894 |
| 2020-08-0516:08 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001558370-20-009387 |
| 2020-08-0516:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-20-009381 |
| 2020-07-0917:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-20-082411 |
| 2020-05-2216:08 ET | 8-K | 5.07 Shareholder vote results | 0001104659-20-065356 |
| 2020-05-0716:27 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001558370-20-005738 |
| 2020-05-0716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-20-005680 |
| 2020-04-0916:01 ET | DEF 14A | Proxy statementPeriod 2020-05-20 | 0001558370-20-003756 |
| 2020-02-2716:09 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001558370-20-001625 |
| 2020-02-2716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-20-026155 |
| 2020-02-1317:10 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-20-020297 |
| 2020-02-1007:14 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-20-012830 |
| 2020-02-0616:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-20-011906 |
| 2020-01-2413:38 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-20-014002 |
| 2020-01-0716:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-20-001982 |
| 2019-11-0616:04 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001558370-19-010153 |
| 2019-11-0616:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-19-060492 |
| 2019-08-0716:03 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001558370-19-007458 |
| 2019-08-0716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-19-044526 |
| 2019-05-0816:03 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001558370-19-004446 |
| 2019-05-0816:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-19-027801 |
| 2019-04-3016:00 ET | 8-K | 5.07 Shareholder vote results | 0001104659-19-025274 |
| 2019-03-1516:01 ET | DEF 14A | Proxy statementPeriod 2019-04-25 | 0001558370-19-002140 |
| 2019-02-2716:07 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001558370-19-001187 |
| 2019-02-2716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-19-011087 |
| 2019-01-0708:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-19-000992 |
| 2018-11-0816:06 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001558370-18-009001 |
| 2018-11-0816:06 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-18-066968 |
| 2018-08-0816:03 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001558370-18-006748 |
| 2018-08-0816:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-18-050488 |
| 2018-06-0416:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-18-037991 |
| 2018-05-2516:01 ET | 8-K | 5.07 Shareholder vote results | 0001104659-18-035995 |
| 2018-05-0916:07 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001558370-18-004474 |
| 2018-05-0916:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-18-031709 |
| 2018-04-1308:22 ET | DEF 14A | Proxy statementPeriod 2018-05-24 | 0001558370-18-002953 |
| 2018-03-0717:13 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001558370-18-001644 |
| 2018-03-0716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-18-015546 |
| 2018-02-2612:09 ET | SC 13D/A | Ownership report, active investor, amended | 0001072613-18-000167 |
| 2018-02-2216:20 ET | 8-K | 8.01 Other events | 0001104659-18-011372 |
| 2018-01-1009:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-18-001560 |
| 2017-12-1417:04 ET | 8-K | 1.02 Termination of a material agreement | 0001104659-17-073384 |
| 2017-12-0416:36 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-17-071702 |
| 2017-12-0418:25 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-17-071469 |
| 2017-11-0816:03 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001558370-17-008530 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 23:07 ET. Listed shows no prices and gives no investment advice.